Immunoregulation by ESAT-6: From Pathogenesis of Tuberculosis to Potential Anti-Inflammatory and Anti-Rejection...

Area of Science:

• Immunology
• Microbiology
• Molecular Biology

Background:

• Early secreted antigenic target of 6 kDa (ESAT-6) is a key virulence factor of Mycobacterium tuberculosis (Mtb).
• ESAT-6 influences host-pathogen interactions, bacterial survival, and cell-to-cell spread.
• Its role in Mtb pathogenicity and immune evasion is complex and multifaceted.

Purpose of the Study:

• To review current knowledge on ESAT-6's role in Mtb infection.
• To analyze ESAT-6's immunomodulatory effects on various immune cells.
• To explore emerging evidence of ESAT-6's anti-inflammatory and immunosuppressive potential.

Main Methods:

• Literature review of studies on ESAT-6 function in Mtb infection.
• Analysis of ESAT-6's impact on macrophages, dendritic cells, neutrophils, and T cells.
• Examination of preclinical data on ESAT-6 in transplant rejection and alloimmunity.

Main Results:

• ESAT-6 contributes to Mtb survival, phagosomal escape, and pathogenicity.
• ESAT-6 exhibits complex immunomodulatory effects, potentially inhibiting or facilitating immune responses.
• Preclinical studies indicate ESAT-6 may suppress transplant rejection and alloimmunity, possibly via regulatory T cells.

Conclusions:

• ESAT-6 plays a significant role in Mtb pathogenesis and host immune modulation.
• Emerging evidence suggests ESAT-6 possesses anti-inflammatory and immunosuppressive properties.
• ESAT-6 holds potential for therapeutic applications in TB and immune-mediated diseases, pending further research.